WIPO has announced that the WIPO Standard ST.26 applies to international applications with nucleotide and/or amino acid sequence listing filed on or after July 1, 2022.
TIPO will fully implement WIPO Standard ST.26 from August 1, 2022. All nucleotide and/or amino acid sequences presented in invention patent applications must comply with the new Standard.
For more information, Please visit:
Taiwan Intellectual Property Office-News-Starting from August 1, 2022, TIPO Will Implement WIPO Standard ST.26 for Nucleotide and/or Amino Acid Sequence Listings Disclosed for Invention Patent Applications
遠碩專利師事務所 | |
Lewis & Davis Patent Attorneys Office | 12F, No. 290, Fuxing North Road, Taipei 10478, Taiwan |
TEL:+886-2-2517-5955 FAX:+886-2-2517-8517 | E-mail:This email address is being protected from spambots. You need JavaScript enabled to view it. |